arrow
P

Pascal Meier

The Institute of Cancer Research
H指数:54
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IAP antagonist tolinapant (ASTX660) in combination with pembrolizumab in advanced solid tumors: a phase I trial

IAP拮抗剂托利那潘特(ASTX660)联合帕博利珠单抗治疗晚期实体瘤:一项I期临床试验

2026-09-300
OA
Author Correction: Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion

作者更正: Palbociclib和dsRNA传感器合作通过ER应激和调节免疫逃避来增强抗癌作用

2025-07-150
OAAI
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models

PARP抑制剂talazoparib与呼肠孤病毒协同作用,在小鼠模型中体内诱导癌症杀伤和肿瘤控制

2025-07-080
OAAI
Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion
2025-05-250
OAAI
RIPK1 is required for ZBP1-driven necroptosis in human cells

RIPK1是ZBP1驱动的坏死性凋亡在人细胞中所需的。

2025-02-210
OA
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death

RIPK1-specific的PROTAC降解剂通过增强免疫原性细胞死亡来实现有效的抗肿瘤活性

IMMUNITY
IF26.3
2024-07-013
OA
Proof-of-concept and preliminary efficacy of triple IAP blockade to maximize immunogenic cell death and induce efficient adaptive immune response: First report on the ASTEROID phase 1 trial
2024-04-050
PRE
Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth (vol 11, 2810, 2020)
2023-09-061
OAAI
Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair
2023-07-2810
OAAI
Apoptotic cell death in disease-Current understanding of the NCCD 2023

疾病中的凋亡细胞死亡-对NCCD 2023的当前理解

2023-04-26143
OAAI
Novel biochemical, structural, and systems insights into inflammatory signaling revealed by contextual interaction proteomics

上下文相互作用蛋白质组学揭示的炎症信号的新型生化,结构和系统见解

2022-09-309
OAAI
ERG activity is regulated by endothelial FAK coupling with TRIM25/USP9x in vascular patterning
2022-07-124
OAAI